Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice: the Japan chronic kidney disease database
H Nagasu, Y Yano, H Kanegae, HJL Heerspink… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE Randomized controlled trials have shown kidney-protective effects of sodium–
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …
glucose cotransporter 2 (SGLT2) inhibitors, and clinical practice databases have suggested …
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
Background Cardiovascular and kidney outcome trials have shown that sodium-glucose co-
transporter-2 (SGLT2) inhibitors slow progression of chronic kidney disease in patients with …
transporter-2 (SGLT2) inhibitors slow progression of chronic kidney disease in patients with …
Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
Objective: To review glucose-lowering efficacy and changes in renal function associated
with sodium-glucose co-transporter 2 (SGLT2) inhibitors among patients with chronic kidney …
with sodium-glucose co-transporter 2 (SGLT2) inhibitors among patients with chronic kidney …
Sodium‐glucose cotransporter‐2 inhibitors and kidney outcomes in real‐world type 2 diabetes populations: A systematic review and meta‐analysis of observational …
AK Forbes, RJ Suckling, W Hinton… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To conduct a systematic review of observational studies to explore the real‐world
kidney benefits of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors in a large and diverse …
kidney benefits of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors in a large and diverse …
SGLT2 inhibitors may offer benefit beyond diabetes
A Kang, MJ Jardine - Nature Reviews Nephrology, 2021 - nature.com
SGLT2 inhibitors may offer benefit beyond diabetes | Nature Reviews Nephrology Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …
content Thank you for visiting nature.com. You are using a browser version with limited support …
SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: a systematic review and meta-analysis
Background Sodium–glucose co-transporter 2 (SGLT2) inhibitors may have renal protective
effects in people with impaired kidney function. We assessed the use of SGLT2 inhibitors in …
effects in people with impaired kidney function. We assessed the use of SGLT2 inhibitors in …
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis
AD Kaze, M Zhuo, SC Kim, E Patorno… - Cardiovascular diabetology, 2022 - Springer
Background We conducted a systematic review and meta-analysis of the cardiovascular,
kidney, and safety outcomes of sodium-glucose cotransporter 2 inhibitors (SGLT2i) among …
kidney, and safety outcomes of sodium-glucose cotransporter 2 inhibitors (SGLT2i) among …
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and …
Aim The use of sodium glucose co‐transporter 2 (SGLT2) inhibitors in patients with type 2
diabetes mellitus (T2DM) and chronic kidney disease (CKD) has been limited, primarily …
diabetes mellitus (T2DM) and chronic kidney disease (CKD) has been limited, primarily …
Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations
CM Khoo, C Deerochanawong… - Diabetes, Obesity …, 2021 - Wiley Online Library
Early onset of type 2 diabetes and a high prevalence of co‐morbidities predispose the Asian
population to a high risk for, and rapid progression of, diabetic kidney disease (DKD). Apart …
population to a high risk for, and rapid progression of, diabetic kidney disease (DKD). Apart …
SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence
JA Davidson - Postgraduate medicine, 2019 - Taylor & Francis
Chronic kidney disease (CKD) is a frequent complication of type 2 diabetes mellitus (T2DM)
and is associated with poor clinical outcomes, including an increased risk of all-cause and …
and is associated with poor clinical outcomes, including an increased risk of all-cause and …
相关搜索
- meta analysis sglt2 inhibitors
- kidney disease sglt2 inhibitors
- kidney outcomes clinical practice
- clinical practice sglt2 inhibitors
- meta analysis kidney disease
- kidney outcomes real world
- outcomes in patients sglt2 inhibitors
- kidney disease outcomes in patients
- kidney outcomes sodium glucose
- cvd real sglt2 inhibitors
- real world sodium glucose
- clinical practice cvd real
- diabetes mellitus sglt2 inhibitors
- kidney disease diabetes mellitus
- kidney outcomes diabetes populations
- renal impairment sglt2 inhibitors